ClinicalTrials.Veeva

Menu

Acute Kidney Injury in Patients Hospitalized With COVID-19

Z

Zhenhua Zen

Status

Completed

Conditions

COVID-19
Acute Kidney Injury
Kidney Function

Study type

Observational

Funder types

Other

Identifiers

NCT04316299
hkyy2020-005 AKI

Details and patient eligibility

About

The kidney may be affected in coronavirus-2019 disease (COVID-19). This study assessed the predictors and outcomes of acute kidney injury (AKI) among individuals with COVID-19.

Enrollment

287 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • COVID-19 pneumonia patients diagnosed by WHO criteria

Exclusion criteria

  • Patients who were younger than 18 years,
  • Patients who had undergone renal replacement therapy (RRT) before admission,
  • Patients whose entire stay lasted for less than 48 hours.

Trial design

287 participants in 2 patient groups

AKI
Description:
COVID-19 patients with acute kidney injury
non-AKI
Description:
COVID-19 patients without acute kidney injury

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems